Valiant Organics Limited, a leading manufacturer of specialty chemicals, held its 20th Annual General Meeting (AGM) on September 26, where shareholders approved several important resolutions, including key appointments and the selection of a new secretarial auditor.

Director Re-appointments

The shareholders re-appointed two directors to the company's board:

1. Shri Mahek M. Chheda was re-appointed as an Executive Director. With over eight years of experience, Chheda brings expertise in finance, marketing, human resources, and business development to the company.

2. Shri Kiritkumar H. Desai was re-appointed as a Non-Executive Director. Desai boasts an impressive 32-year career in research and development and quality control within the chemical and pharmaceutical industries. His experience includes developing more than 200 products.

Both directors will be liable to retire by rotation, as per the company's articles.

New Secretarial Auditor

In a move to enhance corporate governance, the shareholders approved the appointment of M/s Mehta & Mehta as the company's Secretarial Auditor. The firm will serve for five consecutive years, from the financial year 2025-26 to 2029-30. M/s Mehta & Mehta brings over 25 years of experience in legal and secretarial consultancy services to Valiant Organics.

Other Key Developments

The AGM, conducted through video conferencing and other audio-visual means, also addressed several other important matters:

• The company presented its audited financial statements for the year ended March 31.
• Shareholders approved the remuneration for Shri Sathiababu K. Kallada, Managing Director of the company.
• Material related party transactions with several entities, including Aarti Industries Limited and Valiant Laboratories Limited, were approved.
• The remuneration for the Cost Auditor for the financial year 2025-26 was ratified.

Financial Highlights

During the meeting, the company's Executive Director and Chief Financial Officer, Shri Mahek M. Chheda, presented an overview of Valiant Organics' financial performance:

Company Overview

Valiant Organics Limited, incorporated in 1984, is a specialty chemicals manufacturer headquartered in Mumbai, India. The company focuses on producing chemicals for various industries, including agrochemicals, pharmaceuticals, dyes, and pigments. With six manufacturing units across five locations and a total production capacity of 70,000 TPA, Valiant Organics has established itself as a significant player in the chlorophenol derivatives and PNA manufacturing sectors.

The AGM concluded with a Q&A session where shareholders had the opportunity to engage with the management on various aspects of the company's operations and future strategies.

As Valiant Organics moves forward with its newly appointed leadership and auditor, the company aims to strengthen its position in the specialty chemicals market while maintaining its commitment to quality and growth.

Valiant Organics , a leading specialty chemicals manufacturer, has reported a significant improvement in its financial performance for the first quarter. The company's robust results demonstrate a strong recovery and improved operational efficiency across key financial metrics.

Revenue Growth and Operational Performance

The company's revenue from operations reached INR 2,044.00 million, marking a substantial year-on-year growth of 21.7% from INR 1,679.00 million in the corresponding quarter of the previous year. This growth was supported by higher sales volumes and better realizations across its product portfolio.

Valiant Organics' total production volume for the quarter stood at 7,987 MT across all segments, indicating strong operational performance. The Hydrogenation segment emerged as the largest contributor to revenue, accounting for 53% of the total at INR 1,082.00 million. This was followed by the Ammonolysis segment at 23% and the Chlorination segment at 19%.

Profitability and Margin Expansion

The company's profitability showed remarkable improvement:

• Operating EBITDA surged by 58% to INR 248.00 million, compared to INR 157.00 million in the same quarter of the previous year.
• EBITDA margins expanded significantly by 278 basis points to 12.13%, up from 9.35% in the same quarter last year.
• The company turned profitable with a Profit After Tax (PAT) of INR 82.00 million, compared to a loss of INR 6.00 million in the previous year.
• PAT margin improved to 4.01%, a substantial increase from -0.36% in the corresponding quarter.

Segment-wise Performance

Financial Position and Market Capitalization

As of June 30, Valiant Organics maintains a strong financial position:

• The company's net worth stood at INR 5,698.00 million.
• It reported a comfortable net debt to equity ratio of 0.33.
• The market capitalization of Valiant Organics was approximately INR 11,612.00 million.

Operational Highlights

Valiant Organics continues to strengthen its position in the specialty chemicals market:

• The company operates 6 manufacturing units across 5 locations with a total production capacity of 70,000 TPA.
• It maintains a diverse client base across pharmaceuticals, dyes & pigments, agrochemicals, and specialty chemicals industries.
• Valiant Organics is recognized as one of the largest chlorophenol derivatives manufacturers globally and one of the largest domestic PNA manufacturers.

Valiant Organics' Q1 results demonstrate a robust recovery and improved operational efficiency. The significant growth in revenue, substantial margin expansion, and return to profitability position the company well for continued success in the specialty chemicals market.